Vous êtes ici

Validation and Closure of Phase II of the AfCFTA-anchored Pharmaceutical Initiative & Discussion of the Action Plan for Phase III of the Initiative Meeting to Be Held In Nairobi, Kenya

14 octobre, 2022
Validation and Closure of Phase II of the AfCFTA-anchored Pharmaceutical Initiative & Discussion of the Action Plan for Phase III of the Initiative Meeting to Be Held In Nairobi, Kenya

13 October 2022, Addis Ababa, (ECA) - The United Nations Economic Commission for Africa will hold a 3-day meeting for the validation and closure of the second Phase of the AfCFTA-anchored pharmaceutical initiative in Nairobi, Kenya from the 19th –21st October 2022. The meeting will be held to review the three year journey of the initiative with a view to preparing for Phase III.

The overall objective of the meeting is to share the key results obtained during Phase II of the Pharma Initiative with stakeholders and get their buy-in on the Action Plan for the roll out of Phase III. 

The meeting will bring together senior government officials from the 10 pilot countries, representatives of UNECA, WHO, UNAIDS, UNIDO, UNFPA, UNICEF, AUC, AUDA-NEPAD, AfCFTA Secretariat, Africa CDC, IGAD, IFC, AMA and ARSO to share  the results obtained and to outline the way forward for Phase III of the Pharma Initiative

 

For Further information, contact:
Communications Section
AfCFTA-anchored Pharmaceutical Initiative
PO Box 3001
Addis Ababa
Ethiopia
E-mail : karonga@un.org